Researchers assessed whether a set dose of luspatercept could be safe in treating pediatric patients with non–transfusion dependent beta-thalassemia.
This month, Novo Nordisk and Eli Lilly’s decision to cut US prices for their blockbuster obesity drugs was the latest plot twist in President Trump’s tariffs thriller. Look a little closer, though, ...
CSL shares are down roughly 40% since acquiring Vifor in August 2022, an iron deficiency and kidney disease business and the largest acquisition in its history. However, several other factors have ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...
View post: AT&T follows T-Mobile with bold move to win back customers View post: After Rate Cut, Fed Chair Jerome Powell Credits Automation and AI For Contributing to This "Structural" Boom in the U.S ...
Not six months ago, bankers and lawyers had significant reservations whether they could get larger biotechnology deals over the finish line. Questions around interest rates, tariff policies and the ...
The Trump administration reached a deal with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to Britain’s National ...
President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to bear much of the burden of the costs of medicines. By Rebecca Robbins and Eshe Nelson ...
Pharmaceutical companies have agreed to cut prices of 15 prescription drugs on Medicare plans that could result in billions in savings for taxpayers and older adults, the Trump administration said ...
Is it a coincidence the most valuable pharmaceutical company by market capitalization is also the one with the CEO rated highest by employees? Maybe not. Eli Lilly, which just became the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results